Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Perinatal Medicine
|
May 4, 1999
Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban
T Bossmar
Acta Obstetricia Et Gynecologica Scandinavica
|
August 1, 1995
Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women
T Bossmar, M Forsling, M Akerlund
Acta Obstetricia Et Gynecologica Scandinavica
|
July 1, 1996
Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium
T Bossmar, T Rasmussen, M Akerlund
Gynecologic Oncology
|
July 16, 2008
Robot-assisted abdominal laparoscopic radical trachelectomy
J Persson, P Kannisto, T Bossmar
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer
B Casslén, T Bossmar, I Lecander, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
June 1, 2000
Laparoscopic colposuspension: a short term urodynamic follow-up and a three-year questionnaire-study
J Persson, T Bossmar, P Wølner-Hanssen
British Journal of Obstetrics and Gynaecology
|
April 1, 1997
Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions
T Bossmar, R Brouard, A Döberl, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
December 16, 1998
Osmotically-induced release of vasopressin and oxytocin in non-pregnant women--influence of estrogen and progesterone
M Steinwall, M Akerlund, T Bossmar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 16, 2004
ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women
M Steinwall, M Akerlund, T Bossmar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
May 29, 2000
Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea
R Brouard, T Bossmar, D Fournié-Lloret, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Perinatal Medicine
|
May 4, 1999
Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban
T Bossmar
Acta Obstetricia Et Gynecologica Scandinavica
|
August 1, 1995
Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women
T Bossmar, M Forsling, M Akerlund
Acta Obstetricia Et Gynecologica Scandinavica
|
July 1, 1996
Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium
T Bossmar, T Rasmussen, M Akerlund
Gynecologic Oncology
|
July 16, 2008
Robot-assisted abdominal laparoscopic radical trachelectomy
J Persson, P Kannisto, T Bossmar
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer
B Casslén, T Bossmar, I Lecander, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
June 1, 2000
Laparoscopic colposuspension: a short term urodynamic follow-up and a three-year questionnaire-study
J Persson, T Bossmar, P Wølner-Hanssen
British Journal of Obstetrics and Gynaecology
|
April 1, 1997
Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions
T Bossmar, R Brouard, A Döberl, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
December 16, 1998
Osmotically-induced release of vasopressin and oxytocin in non-pregnant women--influence of estrogen and progesterone
M Steinwall, M Akerlund, T Bossmar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
January 16, 2004
ONO-8815Ly, an EP2 agonist that markedly inhibits uterine contractions in women
M Steinwall, M Akerlund, T Bossmar, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
May 29, 2000
Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea
R Brouard, T Bossmar, D Fournié-Lloret, et al.
Page
of 2